HemaSphere
(Aug 2023)
P1362: DEVELOPMENT OF A NOVEL ONCOLYTIC VIRUS -THEO-310 - SPECIALISED FOR TARGETING THE BONE MARROW TUMOUR MICROENVIRONMENT OF MULTIPLE MYELOMA PATIENTS
Rebecca Bamford,
Shayda Maleki-Toyserkani,
Will Taverner,
Josh Freedman,
Matt Hayman,
Manoj Saini,
Sarah Gooding,
Karthik Ramasamy,
Kerry Fisher,
Margaret Duffy
Affiliations
Rebecca Bamford
1 Theolytics, United Kingdom
Shayda Maleki-Toyserkani
1 Theolytics, United Kingdom
Will Taverner
1 Theolytics, United Kingdom
Josh Freedman
1 Theolytics, United Kingdom
Matt Hayman
1 Theolytics, United Kingdom
Manoj Saini
1 Theolytics, United Kingdom
Sarah Gooding
2 University of Oxford, United Kingdom
Karthik Ramasamy
2 University of Oxford, United Kingdom
Kerry Fisher
1 Theolytics, United Kingdom
Margaret Duffy
1 Theolytics, United Kingdom
DOI
https://doi.org/10.1097/01.HS9.0000972336.33493.9c
Journal volume & issue
Vol. 7
p.
e334939c
WeChat QR code
Close